agilon health, inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 25, 2026
agilon health, inc. (Registrant)
/s/ BENJAMIN SHAKER
Benjamin Shaker
Chief Markets Officer and Member of the Office of the Chairman
(Interim Principal Executive Officer)
/s/ JEFFREY SCHWANEKE
Jeffrey Schwaneke
Chief Financial Officer and Member of the Office of the Chairman
(Principal Financial Officer and Interim Principal Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ BENJAMIN SHAKER | Chief Markets Officer and Member of the Office of the Chairman | February 25, 2026 |
| Benjamin Shaker | (Interim Principal Executive Officer) | |
| /s/ JEFFREY SCHWANEKE | Chief Financial Officer and Member of the Office of the Chairman | February 25, 2026 |
| Jeffrey Schwaneke | (Principal Financial Officer and Interim Principal Executive Officer) | |
| /s/ TIMOTHY GERTSCH | Chief Accounting Officer | February 25, 2026 |
| Timothy Gertsch | (Principal Accounting Officer) | |
| /s/ RONALD A. WILLIAMS | Chairman of the Board | February 25, 2026 |
| Ronald A. Williams | ||
| /s/ RAVI SACHDEV | Vice Chairman of the Board | February 25, 2026 |
| Ravi Sachdev | ||
| /s/ SHARAD MANSUKANI, M.D. | Director | February 25, 2026 |
| Sharad Mansukani, M.D. | ||
| /s/ WILLIAM WULF, M.D. | Director | February 25, 2026 |
| William Wulf, M.D. | ||
| /s/ KAREN MCLOUGHLIN | Director | February 25, 2026 |
| Karen McLoughlin | ||
| /s/ DIANA L. MCKENZIE | Director | February 25, 2026 |
| Diana L. McKenzie | ||
| /s/ SILVANA BATTAGLIA | Director | February 25, 2026 |
| Silvana Battaglia | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.